Government response
Draft guidance on individualised mRNA cancer immunotherapies
Published 2025-10-01.
We are seeking feedback on our new draft guideline on individualised mRNA cancer immunotherapies, a new type of cancer treatment being tested in clinical trials. This will help us to clarify and streamline pathways for bringing these therapies through to patients, without compromising on robust safety principles.
§ Publishing organisations